MW3782A1 - Human proinsulin pharmaceutical formulations - Google Patents
Human proinsulin pharmaceutical formulationsInfo
- Publication number
- MW3782A1 MW3782A1 MW37/82A MW3782A MW3782A1 MW 3782 A1 MW3782 A1 MW 3782A1 MW 37/82 A MW37/82 A MW 37/82A MW 3782 A MW3782 A MW 3782A MW 3782 A1 MW3782 A1 MW 3782A1
- Authority
- MW
- MALAWI
- Prior art keywords
- pharmaceutical formulations
- human proinsulin
- proinsulin
- human
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29675281A | 1981-08-27 | 1981-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW3782A1 true MW3782A1 (en) | 1984-06-13 |
Family
ID=23143402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW37/82A MW3782A1 (en) | 1981-08-27 | 1982-08-24 | Human proinsulin pharmaceutical formulations |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS5846023A (xx) |
| AU (1) | AU552054B2 (xx) |
| BE (1) | BE894186A (xx) |
| CA (1) | CA1176160A (xx) |
| CH (1) | CH650677A5 (xx) |
| DE (1) | DE3232036A1 (xx) |
| FR (1) | FR2511866B1 (xx) |
| GB (1) | GB2104380B (xx) |
| HU (1) | HU193522B (xx) |
| IE (1) | IE53829B1 (xx) |
| IL (1) | IL66610A (xx) |
| IT (1) | IT1153184B (xx) |
| LU (1) | LU84358A1 (xx) |
| MW (1) | MW3782A1 (xx) |
| MY (1) | MY8700757A (xx) |
| NL (1) | NL8203316A (xx) |
| NZ (1) | NZ201683A (xx) |
| PH (1) | PH18716A (xx) |
| SE (1) | SE8204871L (xx) |
| ZA (1) | ZA826157B (xx) |
| ZW (1) | ZW17382A1 (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| DE3576120D1 (de) * | 1984-06-09 | 1990-04-05 | Hoechst Ag | Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung. |
| US5034415A (en) * | 1987-08-07 | 1991-07-23 | Century Laboratories, Inc. | Treatment of diabetes mellitus |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| ES2331342B1 (es) * | 2006-05-22 | 2010-10-13 | Consejo Superior Investg.Cientificas | Uso de la proinsulina para la elaboracion de una composicion farmaceutica neuroprotectora, composicion terapeutica que la contiene y sus aplicaciones. |
| USD1010056S1 (en) * | 2020-08-25 | 2024-01-02 | Magpul Industries Corp. | Gun sight |
-
1982
- 1982-08-23 ZW ZW173/82A patent/ZW17382A1/xx unknown
- 1982-08-23 CH CH5008/82A patent/CH650677A5/de not_active IP Right Cessation
- 1982-08-23 IL IL66610A patent/IL66610A/xx unknown
- 1982-08-23 CA CA000409922A patent/CA1176160A/en not_active Expired
- 1982-08-24 NL NL8203316A patent/NL8203316A/nl not_active Application Discontinuation
- 1982-08-24 MW MW37/82A patent/MW3782A1/xx unknown
- 1982-08-24 ZA ZA826157A patent/ZA826157B/xx unknown
- 1982-08-24 BE BE6/47702A patent/BE894186A/fr not_active IP Right Cessation
- 1982-08-24 NZ NZ201683A patent/NZ201683A/en unknown
- 1982-08-24 PH PH27771A patent/PH18716A/en unknown
- 1982-08-25 AU AU87595/82A patent/AU552054B2/en not_active Ceased
- 1982-08-25 HU HU822743A patent/HU193522B/hu unknown
- 1982-08-25 FR FR8214597A patent/FR2511866B1/fr not_active Expired
- 1982-08-25 JP JP57148493A patent/JPS5846023A/ja active Pending
- 1982-08-25 SE SE8204871A patent/SE8204871L/ unknown
- 1982-08-26 LU LU84358A patent/LU84358A1/fr unknown
- 1982-08-26 IE IE2062/82A patent/IE53829B1/en unknown
- 1982-08-26 GB GB08224482A patent/GB2104380B/en not_active Expired
- 1982-08-27 IT IT23019/82A patent/IT1153184B/it active
- 1982-08-27 DE DE19823232036 patent/DE3232036A1/de not_active Withdrawn
-
1987
- 1987-12-30 MY MY757/87A patent/MY8700757A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL8203316A (nl) | 1983-03-16 |
| FR2511866A1 (fr) | 1983-03-04 |
| ZW17382A1 (en) | 1982-11-17 |
| PH18716A (xx) | 1985-09-11 |
| CH650677A5 (de) | 1985-08-15 |
| BE894186A (fr) | 1983-02-24 |
| GB2104380A (en) | 1983-03-09 |
| AU552054B2 (en) | 1986-05-22 |
| CA1176160A (en) | 1984-10-16 |
| NZ201683A (en) | 1985-08-16 |
| IT8223019A0 (it) | 1982-08-27 |
| SE8204871D0 (sv) | 1982-08-25 |
| SE8204871L (sv) | 1983-02-28 |
| LU84358A1 (fr) | 1983-02-28 |
| IE822062L (en) | 1983-02-27 |
| GB2104380B (en) | 1984-12-05 |
| ZA826157B (en) | 1984-04-25 |
| DE3232036A1 (de) | 1983-03-10 |
| IL66610A (en) | 1985-11-29 |
| IE53829B1 (en) | 1989-03-15 |
| FR2511866B1 (fr) | 1986-08-14 |
| HU193522B (en) | 1987-10-28 |
| IT1153184B (it) | 1987-01-14 |
| IL66610A0 (en) | 1982-12-31 |
| JPS5846023A (ja) | 1983-03-17 |
| MY8700757A (en) | 1987-12-31 |
| AU8759582A (en) | 1983-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA828797B (en) | Pharmaceutical formulation | |
| DE3378523D1 (en) | Pharmaceutical formulations | |
| DE3264782D1 (en) | Medicinal formulation | |
| SG21388G (en) | Pharmaceutical formulations | |
| GB2105191B (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
| MW3882A1 (en) | Pharmaceutical formulations comprising human insulin human c-peptide | |
| GB2104380B (en) | Human proinsulin pharmaceutical formulations | |
| DE3466477D1 (en) | Pharmaceutical formulations | |
| ZA822120B (en) | Pharmaceutical preparation | |
| ZA833692B (en) | Pharmaceutical formulations | |
| IE812104L (en) | Novel insulin formulations based on human insulin | |
| IE810190L (en) | Pharmaceutical preparation containing¹poly-glycidyl-substituted n-heterocyclics | |
| GB8316497D0 (en) | Pharmaceutical formulations | |
| GB8319760D0 (en) | Pharmaceutical formulations | |
| GB8300648D0 (en) | Pharmaceutical formulations | |
| GB8313036D0 (en) | Pharmaceutical formulations | |
| GB8316495D0 (en) | Pharmaceutical formulations | |
| GB8316496D0 (en) | Pharmaceutical formulations | |
| GB8319759D0 (en) | Pharmaceutical formulations | |
| GB8316498D0 (en) | Pharmaceutical formulations | |
| GB8332451D0 (en) | Pharmaceutical formulations | |
| IE811106L (en) | Controlled release oral pharmaceutical preparations |